X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (99481) 99481
Newsletter (48368) 48368
Publication (6195) 6195
Newspaper Article (3209) 3209
Transcript (397) 397
Book Review (360) 360
Book Chapter (240) 240
Magazine Article (179) 179
Dissertation (178) 178
Conference Proceeding (115) 115
Trade Publication Article (68) 68
Book / eBook (25) 25
Web Resource (15) 15
Reference (14) 14
Data Set (10) 10
Government Document (3) 3
Streaming Video (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lung cancer, non-small cell (80713) 80713
humans (62896) 62896
cancer (56645) 56645
research (48470) 48470
oncology (35972) 35972
male (34495) 34495
female (33739) 33739
care and treatment (33696) 33696
index medicus (32455) 32455
oncology, experimental (30818) 30818
middle aged (29647) 29647
aged (28018) 28018
lung neoplasms - pathology (27763) 27763
lung cancer (24621) 24621
lung cancer, small cell (23455) 23455
chemotherapy (22665) 22665
lung neoplasms - drug therapy (21358) 21358
carcinoma, non-small-cell lung - pathology (21020) 21020
prognosis (18354) 18354
adult (17901) 17901
carcinoma, non-small-cell lung - drug therapy (17689) 17689
reports (16684) 16684
non-small cell lung cancer (16255) 16255
genetic aspects (12899) 12899
analysis (12760) 12760
metastasis (12596) 12596
lung neoplasms - genetics (12439) 12439
neoplasm staging (12292) 12292
respiratory system (11390) 11390
carcinoma, non-small-cell lung - genetics (11189) 11189
lung neoplasms - mortality (10882) 10882
tumors (10780) 10780
aged, 80 and over (10686) 10686
radiotherapy (9843) 9843
carcinoma (9228) 9228
survival (9181) 9181
lung neoplasms - metabolism (8993) 8993
treatment outcome (8987) 8987
carcinoma, non-small-cell lung - mortality (8907) 8907
antineoplastic combined chemotherapy protocols - therapeutic use (8898) 8898
universities and colleges (8799) 8799
health aspects (8546) 8546
surgery (8446) 8446
lung neoplasms - surgery (7785) 7785
apoptosis (7742) 7742
carcinoma, non-small-cell lung - metabolism (7498) 7498
antineoplastic agents (7439) 7439
medical research (7369) 7369
drug therapy (7233) 7233
antimitotic agents (7184) 7184
expression (7111) 7111
physical fitness (7016) 7016
retrospective studies (6984) 6984
carcinoma, non-small-cell lung - surgery (6883) 6883
cell line, tumor (6841) 6841
mutation (6773) 6773
development and progression (6497) 6497
clinical trials (6453) 6453
survival rate (6404) 6404
animals (6359) 6359
non-small cell lung carcinoma (6277) 6277
medicine, experimental (6198) 6198
lung neoplasms - therapy (6194) 6194
epidermal growth factor (5974) 5974
antineoplastic agents - therapeutic use (5903) 5903
biochemistry (5902) 5902
lung neoplasms - radiotherapy (5852) 5852
adenocarcinoma (5720) 5720
survival analysis (5689) 5689
hematology, oncology and palliative medicine (5627) 5627
diagnosis (5497) 5497
cisplatin (5460) 5460
gefitinib (5379) 5379
immunohistochemistry (5260) 5260
communicable diseases (5225) 5225
cancer therapies (5073) 5073
lung neoplasms - diagnosis (5025) 5025
pharmaceutical industry (4950) 4950
immunotherapy (4936) 4936
patient outcomes (4861) 4861
nsclc (4824) 4824
patients (4785) 4785
carcinoma, non-small-cell lung - radiotherapy (4714) 4714
drugs (4693) 4693
non-small-cell lung cancer (4682) 4682
cell research (4649) 4649
gene expression (4633) 4633
therapy (4621) 4621
carcinoma, non-small-cell lung - therapy (4567) 4567
combined modality therapy (4528) 4528
mice (4424) 4424
respiratory tract diseases (4298) 4298
risk factors (4273) 4273
carcinoma, small cell - pathology (4234) 4234
follow-up studies (3966) 3966
cell lung-cancer (3954) 3954
carcinoma, small cell - drug therapy (3949) 3949
adenocarcinoma - pathology (3901) 3901
proteins (3857) 3857
disease-free survival (3815) 3815
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (143703) 143703
Chinese (1955) 1955
Japanese (1874) 1874
French (1622) 1622
German (887) 887
Korean (379) 379
Russian (375) 375
Polish (364) 364
Spanish (326) 326
Italian (142) 142
Turkish (117) 117
Czech (69) 69
Portuguese (64) 64
Hungarian (55) 55
Dutch (29) 29
Danish (27) 27
Romanian (27) 27
Bulgarian (16) 16
Croatian (12) 12
Swedish (12) 12
Norwegian (11) 11
Serbian (11) 11
Finnish (10) 10
Slovak (10) 10
Hebrew (9) 9
Icelandic (9) 9
Lithuanian (9) 9
Ukrainian (4) 4
Belarusian (1) 1
Bosnian (1) 1
Persian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9804, pp. 1741 - 1755
Journal Article
Clinics in Chest Medicine, ISSN 0272-5231, 12/2011, Volume 32, Issue 4, pp. 669 - 692
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2018, Volume 378, Issue 21, pp. 1976 - 1986
Journal Article
2001, Basic and clinical oncology, ISBN 0824702743, Volume 25., 535
Book
Chest, ISSN 0012-3692, 2016, Volume 151, Issue 1, pp. 193 - 203
Journal Article
2005, Hematology/oncology clinics of North America, ISBN 9781416027737, Volume 19, no. 2., xii, p. 209-426
Book
The New England Journal of Medicine, ISSN 0028-4793, 12/2014, Volume 371, Issue 23, pp. 2167 - 2177
The ALK inhibitor crizotinib as first-line therapy was associated with a significantly better response rate, longer progression-free survival, and greater... 
CRITERIA | MEDICINE, GENERAL & INTERNAL | GEFITINIB | THERAPY | CISPLATIN | ADENOCARCINOMA | PHASE-III | KINASE | ANAPLASTIC LYMPHOMA | QLQ-C30 | PLUS | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Guanine - analogs & derivatives | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Pyridines - adverse effects | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Pyrazoles - adverse effects | Pyridines - therapeutic use | Kaplan-Meier Estimate | Carboplatin - administration & dosage | Adenocarcinoma - drug therapy | Carcinoma, Non-Small-Cell Lung - mortality | Pemetrexed | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Glutamates - administration & dosage | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Guanine - administration & dosage | Appetite | Edema | Inhibitor drugs | Intravenous administration | Biomedical research | Lung cancer | Diarrhea | Non-small cell lung carcinoma | Fatigue | Nausea | Metastasis | Patients | Cisplatin | Quality of life | Chemotherapy | Lungs | Platinum | Vomiting | Comparative studies | Carboplatin
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2013, Volume 8, Issue 3, p. e60317
Aberrant expression of microRNA-146a (miR-146a) has been reported to be involved in the development and progression of various types of cancers. However, its... 
SUPPRESSOR | ONCOGENESIS | RNA | MULTIDISCIPLINARY SCIENCES | CERVICAL-CANCER | INTERFERENCE | MICRORNAS | NF-KAPPA-B | FACTOR RECEPTOR | EXPRESSION | CONTRIBUTES | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Middle Aged | Gene Expression Regulation, Neoplastic | Lung Neoplasms - pathology | Male | MicroRNAs - metabolism | NF-kappa B - metabolism | Receptor, Epidermal Growth Factor - metabolism | Antibodies, Monoclonal, Humanized - pharmacology | Aged, 80 and over | Adult | Female | Antineoplastic Agents - pharmacology | Lung - metabolism | Cetuximab | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung - pathology | Signal Transduction | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Lung - drug effects | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | MicroRNAs - genetics | Carcinoma, Non-Small-Cell Lung - drug therapy | Apoptosis | Cell Movement | MicroRNA | Growth | Monoclonal antibodies | Lung cancer, Small cell | Development and progression | Lung cancer, Non-small cell | Health aspects | Cell proliferation | Laboratories | Lung cancer | Oncology | Drug delivery | Kinases | Paraffin | Cancer therapies | Metastases | Signal transduction | Cell growth | Inhibition | Gefitinib | Sensitizing | NF-κB protein | Phenotypes | Cytokines | Epidermal growth factor receptors | MiRNA | Non-small cell lung carcinoma | siRNA | Breast cancer | Gene expression | Ribonucleic acid--RNA | Patients | Pathology | Signaling | Chemotherapy | Thyroid cancer | MicroRNAs | Medical prognosis | Pancreatic cancer | Cell lines | Biomarkers | Mutation | Cell migration | Cervical cancer | Tumors | Cancer | Ribonucleic acid
Journal Article